AOD-9604 – 5mg
$65.00
AOD-9604 (5mg) is a potent synthetic peptide fragment derived from the C-terminus of Human Growth Hormone (HGH). Specifically designed for metabolic research, AOD (Anti-Obesity Drug) is a primary tool for investigating lipolysis and the inhibition of lipogenesis without the growth-promoting or insulin-sensitizing side effects associated with full-length HGH. Each vial is vacuum-sealed and guaranteed at 99% purity, ensuring the molecular stability required for high-precision metabolic and regenerative studies.
Out of stock
Description
Overview of AOD-9604
AOD-9604 is a stabilized analog of the HGH fragment spanning amino acids 177–191. In research settings, it is highly valued for its ability to isolate the fat-reducing properties of growth hormone. Unlike the parent molecule, AOD-9604 does not stimulate the IGF-1 receptor, meaning it does not induce cellular proliferation or affect blood glucose levels. This makes it an ideal candidate for researchers studying the targeted reduction of adipose tissue and the biochemical pathways of lipid metabolism.
Primary Research Applications
This 5mg formulation is a cornerstone of metabolic and musculoskeletal research, utilized to explore:
-
Lipolysis and Lipogenesis: Investigating the mechanisms by which the peptide stimulates the breakdown of fat (lipolysis) and inhibits the transformation of non-fatty foods into body fat (lipogenesis).
-
Metabolic Regulation: Analyzing the peptide’s impact on fat metabolism in animal models of obesity without influencing systemic growth or insulin resistance.
-
Cartilage and Bone Repair: Emerging studies in 2026 are exploring AOD-9604’s potential in regenerative medicine, specifically its role in stimulating chondrocyte differentiation and repairing damaged cartilage.
-
Proteoglycan Synthesis: Researching the compound’s ability to increase the production of proteoglycans in connective tissues, a key factor in joint health and recovery.
